BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Business

  Lexicon Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update

  Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results for the three months ended March 31, 2023 and provided an update on key corporate milestones.

  May 2, 2023

   · 

  7 min read
• Business

  Minerva Surgical Reports First Quarter 2023 Financial Results

  Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company) today reported first quarter financial results for the period ended March 31, 2023.

  May 2, 2023

   · 

  10 min read
• Business

  Acumen Pharmaceuticals to Report First Quarter Financial Results on May 9, 2023

  Acumen Pharmaceuticals, Inc. announced that the Company will report first quarter financial results on Tuesday, May 9, 2023.

  May 2, 2023

   · 

  1 min read
• Business

  Biomea Fusion Reports First Quarter 2023 Financial Results and Corporate Highlights

  Biomea Fusion, Inc. reported first quarter 2023 financial results and business highlights.

  May 2, 2023

   · 

  11 min read
• Business

  MIMEDX Announces First Quarter 2023 Operating and Financial Results

  MiMedx Group, Inc., a pioneer and leader in placental biologics, announced operating and financial results for the first quarter 2023, which ended March 31, 2023, including net sales of $71.7 million, net loss of $5.0 million and Adjusted EBITDA of $5.5 million.

  May 2, 2023

   · 

  15 min read
• BioCapital

  Supernus to Present at the Bank of America 2023 Health Care Conference

  Supernus Pharmaceuticals, Inc. announced that Jack Khattar, President and CEO of Supernus Pharmaceuticals, will participate in a fireside chat, as well as host investor meetings, at the Bank of America 2023 Health Care Conference on Thursday, May 11, 2023, at 10:40 a.m. PT.

  May 2, 2023

   · 

  4 min read
• Genetown

  LeMaitre Q1 2023 Financial Results

  LeMaitre, a provider of vascular devices, implants and services, reported Q1 2023 results, announced a $0.14/share quarterly dividend and provided guidance.

  May 2, 2023

   · 

  12 min read
• Biotech Beach

  Neurocrine Biosciences to Present at the Bank of America Securities 2023 Healthcare Conference

  Neurocrine Biosciences, Inc. will present at the Bank of America Securities 2023 Healthcare Conference at 10:00 a.m. Pacific Time on Tuesday, May 9, 2023.

  May 2, 2023

   · 

  1 min read
• Business

  BioLife Solutions to Provide First Quarter 2023 Financial Results and Business Update on May 10, 2023

  BioLife Solutions, Inc., a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies and broader biopharma markets, announced the Company’s first quarter financial results will be released after market close on Wednesday, May 10, 2023.

  May 2, 2023

   · 

  1 min read
• BioMidwest

  University Cancer & Blood Center announces opening date of state-of-the art Comprehensive Cancer Treatment Center

  University Cancer & Blood Center will open its Comprehensive Cancer Center in August, offering a fully integrated approach to cancer care with incomparable, convenient access.

  May 2, 2023

   · 

  2 min read